March 20, 2026

FDA Approves Chemoimmunotherapy Regimen for Hodgkin Lymphoma

Nivolumab (Opdivo) with doxorubicin, vinblastine, and dacarbazine (AVD) was approved today for adult and pediatric patients aged 12 years and older with previously untreated stage III or IV classical ...

The ASCO Post

March 20, 2026

Hypofractionated Locoregional RT in Early Breast Cancer

As reported in The Lancet by Rivera et al, 5-year results of a French phase III trial (UNICANCER HypoG-01) showed noninferiority of hypofractionated locoregional radiotherapy (RT) vs standard 5-week R...

The ASCO Post

March 18, 2026

Timely Scans May Reduce Mortality in Patients Who Present to the ER With Hematuria

One in 10 patients who present to the emergency room (ER) with visible hematuria die within 3 months, new research from the United Kingdom has indicated. The WASHOUT study found that a scan administer...

The ASCO Post

March 17, 2026

2025 San Antonio Breast Cancer Symposium Panel Discussion

Harold Burstein, MD, PhD; Sara Tolaney, MD, MPH; Nancy Lin, MD; Sarah Sammons, MD; Ana C. Garrido-Castro, MD; and Elizabeth Ann Mittendorf, MD, PhD, MHCM, discuss important breast cancer research presented at the 2025 San Antonio Breast Cancer Symposium.

Dana-Farber

March 17, 2026

Romiplostim May Improve Chemotherapy-Induced Thrombocytopenia in Patients With GI Cancers

Romiplostim was beneficial in treating chemotherapy-induced thrombocytopenia, according to findings from the global phase III RECITE trial published in The New England Journal of Medicine.  

The ASCO Post

March 16, 2026

New Phase I/II Trial Using Multimodal PDT for Advanced, Recurrent Colorectal Cancer

Long a pioneer in innovative treatments for colorectal cancer, Roswell Park Comprehensive Cancer Center is recruiting patients with locally advanced or recurring colorectal cancer for a new trial involving photodynamic therapy, a technology created here in the 1970s.

Roswell Park Comprehensive Cancer Center

March 16, 2026

Management of Myelodysplastic Syndromes: Emerging Therapies and Evidence-Based Practice

Advancements in MDS therapy are reshaping patient care with a focus on personalized treatment and quality of life improvement.

JADPRO

March 16, 2026

Cancer Surgery: How Can Doctors Set Realistic Patient Expectations About Results?

A Keck Medicine of USC breast surgeon shares best practices to keep patients informed about treatment steps and expectations.

Keck Medicine of USC

March 16, 2026

Optical Genome Mapping Detects Additional Genetic Variants in Nearly 20% of Individuals With Acute Leukemia

By providing a single, genome-wide view, optical genome mapping captured genetic changes across the full spectrum of size and complexity, overcoming limitations in resolution and scope in conventional...

The ASCO Post

March 13, 2026

Female Reproductive Cancers Linked to Reduced Survival Advantage Over Males

Although females live longer than males on average, a large international study suggested that breast and gynecologic cancers reduce their total survival and advantage.

The ASCO Post